TAVR in Small Annuli: Is There a Better Valve?

Transcatheter aortic valve replacement with the self-expandable valves has shown optimal clinical and electrocardiographic results in patients with small annuli. These supra-annular prosthetic valves seem somewhat better than the intra-annular balloon expandable. 

tavi calcificación del anillo mitral

TAVR in general has better functional results in terms of patient/prosthesis mismatch. This seems especially true for patients with a small annulus. 

The TAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annulus) is a retrospective study of aortic stenosis patients with small annuli (annulus perimeter <72 mm and annulus area <400 mm2) by CT and treated with self-expandable valves (Evolut R, n=397; Evolut PRO, n=84; ACURATE, n=201 and Portico, n=177). 

Primary endpoints were post-procedural mean aortic gradient, indexed effective orifice area, and rate of severe prosthesis-patient mismatch. 


Read also: Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus.


Gradients were consistently low across groups with a small but significant benefit in favor of Evolut R (mean gradient 8.1 mmHg) and Evolut PRO (mean gradient 6.9 mmHg) compared with the ACURATE (mean gradient 9.6 mmHg) and the Portico (mean gradient 8.9 mmHg).

The indexed effective orifice area resulted 1.04 cm2/m2 with a trend to lower values for the Portico.

There were no significant differences as regards rates of mismatch (general 9.4%), need for pacemaker (15.6%) and periprocedural and one-year adverse events.


Read also: Small Aortic Annulus: What Valve Should We choose?


More than mild paravalvular leaks resulted more frequent with the Portico (19.2%) and less frequent with the Evolut PRO (3.6%), with intermediate values for Evolut R and Acurate.

Conclusion

The self-expandable valves most frequently used in the clinical practice showed optimal results, both clinic and echocardiographic, to treat patients with severe aortic stenosis and small annuli.  

Original title: Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli. The TAVI-SMALL Registry.

Reference: Damiano Regazzoli et al. J Am Coll Cardiol Intv 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...